JP Morgan Chase
ETRM

JP Morgan Chase’s EnteroMedics Inc. ETRM Stock Holding History

JP Morgan Chase’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2
Closed – – 5468
2016
Q4 		$0 Buy
+2
New +$10 ﹤0.01% 5360

Other funds holding ETRM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JP Morgan Chase's ETRM Position: Q1 2017 in Review

JP Morgan Chase sold out of EnteroMedics Inc. (ETRM) in Q1 2017, closing a stake of 2 shares.

JP Morgan Chase first reported a position in ETRM in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 26 funds tracked by Wall St. Rank hold ETRM as of Q1 2017.

  • JP Morgan Chase reported no remaining EnteroMedics Inc. position as of Q1 2017 after selling out during the quarter.
  • JP Morgan Chase sold 2 EnteroMedics Inc. shares in Q1 2017.
  • JP Morgan Chase first reported a position in EnteroMedics Inc. in Q4 2016 and held it in 1 quarter.
  • JP Morgan Chase's EnteroMedics Inc. position peaked at $0 in Q4 2016.
  • 26 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2017.

Based on JP Morgan Chase's 13F filing for Q1 2017, filed 10 May 2017.